Login
Forgot Password?
New user? Sign up here
Register
Already Registered? Sign in here
Complete Your Profile
Change Password
Request a Password Reset
Enter your email below and we will send you instructions to reset your password.
Download Documents
Tender Notice
Download
Contract Award Notice
Get Help to Participate in This Tender
Our team will contact you shortly.
Your activation form is pending.
Please submit it to start receiving email alerts.
Home » Search RFP » Latest Global Trastuzumab RFP & RFQ
Supply of Injection Ado-Trastuzumab Emtansine / Trastuzumab Emtansine Injection 160 Mg Vial at Ajmer
Deadline: 01 Sep 2025
India
TOT Reference No.: 124402019
Supply of Eye Drop Dorzolamide 2% Ip 5 Ml, Injection Trastuzumab 440 Mg Vial/Ampoule at Ajmer
TOT Reference No.: 124401959
Inj. Trastuzumab 440 Mg Vial
Deadline: 18 Aug 2025
TOT Reference No.: 124331448
Pertuzumab 600Mg + Trastuzumab 600Mg Inj in Vial
Deadline: 11 Aug 2025
TOT Reference No.: 124207976
Supply of Pvms no 011054, Inj Trastuzumab Emtansine (Tdm-1) Vial of 100Mg
Deadline: 09 Sep 2025
TOT Reference No.: 124178654
Pertuzumab/Trastuzumab Inj. 1200Mg/600Mg Drug Procurement Case
Deadline: 19 Aug 2025
Taiwan
TOT Reference No.: 124113746
Inj. Pertuzumab 600Mg + Trastuzumab 600Mg
Deadline: 08 Aug 2025
TOT Reference No.: 124054970
Purchase by Pmbrolizumab 100 Mg 4 Ml Supply
Chile
TOT Reference No.: 124003036
Replacement Medications for 3 Months 28
TOT Reference No.: 124003054
Acquire the Specific Medicines
Deadline: 15 Aug 2025
Brazil
TOT Reference No.: 123987130
Deadline: {{rowDetails.Bid_Deadline_1}}
{{rowDetails.Country_Name}}
TOT Reference No.: {{rowDetails.ID}}
No Data Found..!!
AFRICA TENDERS
AMERICAS TENDERS
Browse Tenders from below Sections
Regions
Countries
geo-political
funding agencies
Sectors
Indian states
Indian cities
purchasers
Fill form below to get callback from Tender Experts.
Thanks for contacting Tendersontime. Someone from our team will contact you within 24 Hrs.
Something Went Wrong !! Please Try Again.
Click button to send your details.